- $56.45m
- $42.36m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 2.71 | ||
| Price to Tang. Book | 2.92 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 81.94 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -180.25% | ||
| Return on Equity | -185.9% | ||
| Operating Margin | -10534.98% | ||
Financial Summary
| Year End 31st Mar | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | 7.72 | 1.39 | 0.87 | n/a | n/a | 1.44 | 13.2 | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Beyond Air, Inc. is a commercial-stage medical device and biopharmaceutical company developing a platform of nitric oxide (NO) generators and delivery systems (the LungFit platform) capable of generating NO from ambient air. The Company’s LungFit platform can be used to treat patients on ventilators that require NO, as well as patients with chronic or acute severe lung infections through delivery through a breathing mask or similar apparatus. The Company’s areas of focus with LungFit are persistent pulmonary hypertension of the newborn (PPHN), viral community-acquired pneumonia (VCAP), including COVID-19, bronchiolitis (BRO), nontuberculous mycobacteria (NTM) lung infection and various severe lung infections with underlying chronic obstructive pulmonary disease (COPD). Its LungFit PH is an ionizer technology that generates on-demand NO from ambient air and, regardless of dose or flow, delivers it to a ventilator circuit. The LungFit can generate up to 400 parts per million (ppm) of NO.
Directors
- Steven Lisi CHM (51)
- Amir Avniel PRE (48)
- Douglas Larson CFO (51)
- Andrew Colin OTH
- Ron Bentsur IND (56)
- Robert Carey IND (63)
- William Forbes IND (60)
- Yoori Lee IND (49)
- Erick Lucera IND (54)
- Last Annual
- March 31st, 2023
- Last Interim
- December 31st, 2023
- Incorporated
- April 28th, 2015
- Public Since
- May 7th, 2019
- No. of Shareholders
- 101
- No. of Employees
- 98
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
NASDAQ Capital Market- Shares in Issue
- 45,898,321
- Address
- 900 STEWART AVENUE, SUITE 301, GARDEN CITY, 11530
- Web
- https://www.beyondair.net/
- Phone
- +1 5166658200
- Auditors
- Friedman LLP
Upcoming Events for XAIR
Q1 2025 Beyond Air Inc Earnings Release
Similar to XAIR
Accelerate Diagnostics
NASDAQ Capital Market
Acutus Medical
NASDAQ Capital Market
Adapthealth
NASDAQ Capital Market
Aethlon Medical
NASDAQ Capital Market
Agape ATP
NASDAQ Capital Market
FAQ
What is the Beyond Air share price?
As of Today at 19:03 UTC, shares in Beyond Air are trading at $1.23. This share price information is delayed by 15 minutes.
How has the Beyond Air share price performed this year?
Shares in Beyond Air last closed at $1.23 and the price had moved by -78.35% over the past 365 days. In terms of relative price strength the Beyond Air share price has underperformed the S&P500 Index by -81.98% over the past year.
What are the analyst and broker recommendations for Beyond Air?
The overall consensus recommendation for Beyond Air is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Beyond Air dividend yield?
Beyond Air does not currently pay a dividend.
Does Beyond Air pay a dividend?
Beyond Air does not currently pay a dividend.
When does Beyond Air next pay dividends?
Beyond Air does not currently pay a dividend.
How do I buy Beyond Air shares?
To buy shares in Beyond Air you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Beyond Air?
As of the previous close price of $1.23, shares in Beyond Air had a market capitalisation of $56.45m.
Where are Beyond Air shares listed?
Here are the trading details for Beyond Air:
- Country of listing: United States
- Exchange: NAQ
- Ticker Symbol: XAIR
What kind of share is Beyond Air?
Based on an overall assessment of its quality, value and momentum Beyond Air is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Beyond Air share price forecast for 2024?
The analyst consensus target price for shares in Beyond Air is $12.00. That is 875.61% above the last closing price of $1.23.
Analysts covering Beyond Air currently have a consensus Earnings Per Share (EPS) forecast of -$1.95 for the next financial year.
What is the trend in the Beyond Air share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Beyond Air. Over the past six months, its share price has underperformed the S&P500 Index by -54.6%.
As of the last closing price of $1.23, shares in Beyond Air were trading -45.11% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Beyond Air PE Ratio?
The Beyond Air PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Beyond Air?
Beyond Air's management team is headed by:
- Steven Lisi - CHM
- Amir Avniel - PRE
- Douglas Larson - CFO
- Andrew Colin - OTH
- Ron Bentsur - IND
- Robert Carey - IND
- William Forbes - IND
- Yoori Lee - IND
- Erick Lucera - IND